AUSTIN, Texas--(BUSINESS WIRE)--February 21 in Philadelphia, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned, with a goal to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.
“Precision Medicine for Hospital CEOs: What You Need to Know about Genetic Testing, Precision Medicine, and Population Health Management” is a focused, one-day conference. It takes place at the Convene Cira Center adjacent to Philadelphia’s 30th Street Amtrak Station. Hospital CEOs and senior administrators can take the train in the morning, learn from and network from the nation’s Precision Medicine innovators, and be home in the evening.
Keynote speaker is David T. Feinberg, MD, CEO, of Geisinger Health in Danville, PA. His health system is internationally recognized for its pioneering efforts to bring precision medicine into daily clinical care. Feinberg will discuss strategies in genetic medicine, how its MyCode Community Health Initiative has DNA sequences for almost 100,000 patients and is returning results to patients who are at risk for 27 conditions. The session will yield essential insights into the early successes of precision medicine at Geisinger Health, and how the healthcare big database at Geisinger will be used to inform population health initiatives while also guiding the care that clinicians deliver daily to individual patients.
Four more expert speakers will share their respective experiences at bringing precision medicine, genetic medicine, and genetic testing into the daily care provided to their patients, as follows:
- Pursuing Precision Medicine in Oncology and Cancer Care: John Deeken, MD, Senior VP and COO, Inova Health System
- Use of Precision Medicine in Infectious Disease and Anti-Microbial Stewardship: Karen Kaul, MD, PhD, Chair, Department of Pathology and Laboratory Medicine, NorthShore University Health System
- Precision Medicine in Pharmacogenomics: Richard Weinshilboum, MD, Professor of Medicine and Pharmacology, Mayo Clinic
- Using Healthcare Big Data to Advance Precision Medicine: John Quackenbush, PhD, Professor of Computational Biology and Bioinformatics, Dana-Farber Cancer Institute
For more information about this ideal opportunity to get access in a networking environment to the most influential hospital sector members in the Precision Medicine field, to gain high-level Precision Medicine business strategies, and to learn from the successes of the first-movers, click here.
